Brokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $32.20
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month […]
